Drug class
First-generation alkylamine H1-histamine receptor antagonist
Mechanism of action
Competitively antagonises peripheral H1 histamine receptors, reducing histamine-mediated allergic symptoms. It crosses the blood–brain barrier and may cause sedation and anticholinergic effects.
General use cases
- Symptomatic relief of sneezing, rhinorrhoea, itchy or watery eyes and other allergic-rhinitis symptoms
- Used in some combination cough-and-cold products; the indication and age limits depend on the specific combination and jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
